Quality of life and symptom data are essential for informing treatment plans as a clinician, as Esther Oliva, MD, of the Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Reggio Calabria, Italy, discusses at the 23rd Congress of the European Hematology Association (EHA) 2018, held in Stockholm, Sweden. As of yet, there is no specific instrument for collecting such data from patients with hematological malignancies. Dr Oliva gives an overview of the content and potential for a specific instrument such as this, and outlines why such a resource is needed.
HMPRO: collecting specific QoL and symptom data for hematological malignancies
